<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03154814</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160051</org_study_id>
    <nct_id>NCT03154814</nct_id>
  </id_info>
  <brief_title>Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass</brief_title>
  <official_title>High-dose Ulinastatin Improves Postoperative Oxygenation in Patients Undergoing Aortic Valve Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study determine whether ulinastatin enhances postoperative pulmonary
      oxygenation after cardiopulmonary bypass (CPB).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This retrospective study evaluate patients who underwent aortic valvular surgery under
      moderate hypothermic CPB. The patients were classified into two groups: patients in whom
      high-dose ulinastatin (10,000 U/kg and 5,000 U/kg/h) was administered during CPB (Group-U);
      and patients in whom ulinastatin was not administered (Group-C). We measured PaO2/FiO2 at the
      following time points: before CPB (Pre-CPB), 2 hours after weaning from CPB (Post-CPB) and
      within 6 hours after admission to the ICU. The lengths of ventilator care and ICU stay were
      also reviewed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">May 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 1, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Retrospective cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of arterial oxygen partial pressure (PaO2)/fraction of inspired oxygen (FiO2) during CPB</measure>
    <time_frame>before CPB (Day 0), 2hours after CPB(Day 0), within 6hour after admission to intensive care unit(Day 0)</time_frame>
    <description>pulmonary oxygenation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Cardiopulmonary Bypass</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>ulinastatin treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ulinastatin (10000 U/kg and 5000 U/kg/h) was administered during CPB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>conventional CPB was applied without ulinastatin treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ulinastatin</intervention_name>
    <description>ulinastatin (10000 U/kg and 5000 U/kg/h) was administered during CPB</description>
    <arm_group_label>ulinastatin treatment</arm_group_label>
    <other_name>ulinastatin administration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>control</intervention_name>
    <description>conventional CPB was applied without ulinastatin treatment</description>
    <arm_group_label>control</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who underwent aortic repair or replacement under moderate hypothermic CPB

        Exclusion Criteria:

          -  Preoperative:

        &lt; 19 years old, &gt; 85 years old, emergency operation, reoperation, left ventricular ejection
        fraction &lt; 50%, arrhythmia, ischaemic myocardial disease, uncontrollable hypertension or
        hypotension, pericardial disease, pre-existing hepatic dysfunction, pre-existing renal
        dysfunction or underlying lung disease.

          -  Intraoperative:

        intraoperative application of an intra-aortic balloon pump, administration of steroids or
        tranexamic acid, and transfusion of fresh frozen plasma or platelet concentrates during
        CPB.

          -  Postoperative:

        reoperation for surgical correction of intractable postoperative bleeding within 2 hours
        after the end of surgery and transfusion of any banked blood products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tae-yop Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>133-798</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2017</study_first_posted>
  <last_update_submitted>May 14, 2017</last_update_submitted>
  <last_update_submitted_qc>May 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>ulinastatin</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>cardiac surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

